Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: Strategy to study HIV preclinical interventions in nonhuman primates

Ron A. Otten, Debra R. Adams, Caryn N. Kim, Eddie Jackson, Jennifer K. Pullium, Kemba Lee, Lisa A. Grohskopf, Michael Monsour, Sal Butera, Thomas M. Folks

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

A nonhuman-primate model of human immunodeficiency virus type 1 (HIV-1) infection that more closely emulates human heterosexual transmission by use of multiple exposures to low doses of virus is critical to better evaluate intervention strategies that include microbicides or vaccines. In this report, we describe such a system that uses female pig-tailed macaques exposed vaginally to a CCR5-using simian-human immunodeficiency virus (SHIVSFI62P3) at weekly intervals. Results of dose-titration experiments indicated that 3 once-weekly exposures to 10 tissue culture infectious doses of SHIV SFI62P3 resulted in consistent transmission of virus and establishment of systemic infection. The efficacy of cellulose acetate phthalate (CAP) as a vaginal microbicide was evaluated by applying it to the vaginal vault of macaques (n = 4) 15 min before each weekly exposure to SHIV SF162P3. One conclusion that can be drawn from the data derived from multiple exposures to virus is that CAP prevented infection in 12 of 13 possible chances for infection, over the course of 39 total exposures. Our findings provide a basis to refine monkey models for transmission of HIV-1, which may be relevant to preclinical evaluation for therapeutic interventions.

Original languageEnglish (US)
Pages (from-to)164-173
Number of pages10
JournalJournal of Infectious Diseases
Volume191
Issue number2
DOIs
StatePublished - Jan 15 2005
Externally publishedYes

Fingerprint

Simian Immunodeficiency Virus
Primates
HIV
Macaca
Anti-Infective Agents
Viruses
HIV-1
Infection
Heterosexuality
Virus Diseases
Haplorhini
Swine
Vaccines
cellulose acetate phthalate
Therapeutics

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus : Strategy to study HIV preclinical interventions in nonhuman primates. / Otten, Ron A.; Adams, Debra R.; Kim, Caryn N.; Jackson, Eddie; Pullium, Jennifer K.; Lee, Kemba; Grohskopf, Lisa A.; Monsour, Michael; Butera, Sal; Folks, Thomas M.

In: Journal of Infectious Diseases, Vol. 191, No. 2, 15.01.2005, p. 164-173.

Research output: Contribution to journalArticle

Otten, RA, Adams, DR, Kim, CN, Jackson, E, Pullium, JK, Lee, K, Grohskopf, LA, Monsour, M, Butera, S & Folks, TM 2005, 'Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: Strategy to study HIV preclinical interventions in nonhuman primates', Journal of Infectious Diseases, vol. 191, no. 2, pp. 164-173. https://doi.org/10.1086/426452
Otten, Ron A. ; Adams, Debra R. ; Kim, Caryn N. ; Jackson, Eddie ; Pullium, Jennifer K. ; Lee, Kemba ; Grohskopf, Lisa A. ; Monsour, Michael ; Butera, Sal ; Folks, Thomas M. / Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus : Strategy to study HIV preclinical interventions in nonhuman primates. In: Journal of Infectious Diseases. 2005 ; Vol. 191, No. 2. pp. 164-173.
@article{bd2f323c925149e1850c5d47db2824aa,
title = "Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: Strategy to study HIV preclinical interventions in nonhuman primates",
abstract = "A nonhuman-primate model of human immunodeficiency virus type 1 (HIV-1) infection that more closely emulates human heterosexual transmission by use of multiple exposures to low doses of virus is critical to better evaluate intervention strategies that include microbicides or vaccines. In this report, we describe such a system that uses female pig-tailed macaques exposed vaginally to a CCR5-using simian-human immunodeficiency virus (SHIVSFI62P3) at weekly intervals. Results of dose-titration experiments indicated that 3 once-weekly exposures to 10 tissue culture infectious doses of SHIV SFI62P3 resulted in consistent transmission of virus and establishment of systemic infection. The efficacy of cellulose acetate phthalate (CAP) as a vaginal microbicide was evaluated by applying it to the vaginal vault of macaques (n = 4) 15 min before each weekly exposure to SHIV SF162P3. One conclusion that can be drawn from the data derived from multiple exposures to virus is that CAP prevented infection in 12 of 13 possible chances for infection, over the course of 39 total exposures. Our findings provide a basis to refine monkey models for transmission of HIV-1, which may be relevant to preclinical evaluation for therapeutic interventions.",
author = "Otten, {Ron A.} and Adams, {Debra R.} and Kim, {Caryn N.} and Eddie Jackson and Pullium, {Jennifer K.} and Kemba Lee and Grohskopf, {Lisa A.} and Michael Monsour and Sal Butera and Folks, {Thomas M.}",
year = "2005",
month = "1",
day = "15",
doi = "10.1086/426452",
language = "English (US)",
volume = "191",
pages = "164--173",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus

T2 - Strategy to study HIV preclinical interventions in nonhuman primates

AU - Otten, Ron A.

AU - Adams, Debra R.

AU - Kim, Caryn N.

AU - Jackson, Eddie

AU - Pullium, Jennifer K.

AU - Lee, Kemba

AU - Grohskopf, Lisa A.

AU - Monsour, Michael

AU - Butera, Sal

AU - Folks, Thomas M.

PY - 2005/1/15

Y1 - 2005/1/15

N2 - A nonhuman-primate model of human immunodeficiency virus type 1 (HIV-1) infection that more closely emulates human heterosexual transmission by use of multiple exposures to low doses of virus is critical to better evaluate intervention strategies that include microbicides or vaccines. In this report, we describe such a system that uses female pig-tailed macaques exposed vaginally to a CCR5-using simian-human immunodeficiency virus (SHIVSFI62P3) at weekly intervals. Results of dose-titration experiments indicated that 3 once-weekly exposures to 10 tissue culture infectious doses of SHIV SFI62P3 resulted in consistent transmission of virus and establishment of systemic infection. The efficacy of cellulose acetate phthalate (CAP) as a vaginal microbicide was evaluated by applying it to the vaginal vault of macaques (n = 4) 15 min before each weekly exposure to SHIV SF162P3. One conclusion that can be drawn from the data derived from multiple exposures to virus is that CAP prevented infection in 12 of 13 possible chances for infection, over the course of 39 total exposures. Our findings provide a basis to refine monkey models for transmission of HIV-1, which may be relevant to preclinical evaluation for therapeutic interventions.

AB - A nonhuman-primate model of human immunodeficiency virus type 1 (HIV-1) infection that more closely emulates human heterosexual transmission by use of multiple exposures to low doses of virus is critical to better evaluate intervention strategies that include microbicides or vaccines. In this report, we describe such a system that uses female pig-tailed macaques exposed vaginally to a CCR5-using simian-human immunodeficiency virus (SHIVSFI62P3) at weekly intervals. Results of dose-titration experiments indicated that 3 once-weekly exposures to 10 tissue culture infectious doses of SHIV SFI62P3 resulted in consistent transmission of virus and establishment of systemic infection. The efficacy of cellulose acetate phthalate (CAP) as a vaginal microbicide was evaluated by applying it to the vaginal vault of macaques (n = 4) 15 min before each weekly exposure to SHIV SF162P3. One conclusion that can be drawn from the data derived from multiple exposures to virus is that CAP prevented infection in 12 of 13 possible chances for infection, over the course of 39 total exposures. Our findings provide a basis to refine monkey models for transmission of HIV-1, which may be relevant to preclinical evaluation for therapeutic interventions.

UR - http://www.scopus.com/inward/record.url?scp=19944428117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19944428117&partnerID=8YFLogxK

U2 - 10.1086/426452

DO - 10.1086/426452

M3 - Article

C2 - 15609225

AN - SCOPUS:19944428117

VL - 191

SP - 164

EP - 173

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 2

ER -